today PT-141, also known as Bremelanotide, is a research peptide that has shown promise in scientific studies, on animal test subjects, to regulate blood flow restriction, inflammation, and helping improve sexual dysfunction
This included significant reductions in the incidence of CV death, nonfatal myocardial infarction and nonfatal stroke (Lincoff et al, 2023)
Both cited the changes to GLP-1 coverage, among other cost-savings, as major factors
What exactly is in the blend
While commonly offered as an injectable medication, our new patented base allows us to improve the accessibility of GLP-1 class medications for weight loss
When tested in musk shrews (a species that, unlike rodents, can vomit), TDN reduced weight without triggering emesis, while exendin-4 caused rapid, dose-dependent vomiting